Colistimethate Sodium for Injection IP 2MIU Manufacturing Companies

Description: Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 2MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP 2MIU include Slurred speech, upset stomach, gastrointestinal disturbance, generalized itching, red spots or bumps, increased blood urea nitrogen, increased creatinine level in blood, decreased creatinine clearance, respiratory distress, apnea (absence of breathing), renal toxicity, decreased urinary volume, dizziness, paresthesia (tingling or pricking sensation), vertigo, rash, and fever. Taj Pharma is a prominent manufacturer and exporter of Colistimethate Sodium for Injection IP 2MIU in India, offering superior pharmaceutical products that meet global healthcare standards. Produced in WHO-GMP and ISO-certified facilities in Vapi, Gujarat, this critical antibiotic is designed to combat life-threatening bacterial infections, particularly those caused by multi-drug resistant Gram-negative bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii. Colistimethate Sodium for Injection IP 2MIU is typically administered in hospital settings under professional supervision. It is especially valuable in ICU treatments, where patients require rapid and effective antibiotic action. Taj Pharma’s formulation is known for its clinical reliability, safety profile, and optimal efficacy, making it a preferred choice for hospitals and healthcare providers globally. Taj Pharma supports PAN India distribution, PCD Pharma Franchise partnerships, and international export to Africa, the Middle East, and LATAM. With a strong focus on quality control, competitive pricing, and comprehensive documentation support, Taj Pharma ensures timely delivery and global accessibility. Taj Pharma India is Top known Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 2MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Dimensions: 2560 x 1707

File Type: jpeg

File Size: 271 KB